1. Home
  2. RDNT vs BLLN Comparison

RDNT vs BLLN Comparison

Compare RDNT & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$60.67

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$118.17

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDNT
BLLN
Founded
1985
2016
Country
United States
United States
Employees
N/A
713
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
RDNT
BLLN
Price
$60.67
$118.17
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$82.80
$126.71
AVG Volume (30 Days)
844.5K
782.3K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,616,630,000.00
N/A
Revenue This Year
$22.78
$46.29
Revenue Next Year
$10.70
$30.14
P/E Ratio
N/A
N/A
Revenue Growth
13.05
N/A
52 Week Low
$50.79
$61.96
52 Week High
$85.84
$138.70

Technical Indicators

Market Signals
Indicator
RDNT
BLLN
Relative Strength Index (RSI) 60.81 67.16
Support Level $58.46 $79.07
Resistance Level $59.98 $138.70
Average True Range (ATR) 2.86 6.87
MACD 0.55 1.10
Stochastic Oscillator 85.30 97.91

Price Performance

Historical Comparison
RDNT
BLLN

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: